Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Viragen and University of Miami advance cancer study

May 17, 2004

IND clearance for phase III trial of Rencarex in renal cell carcinoma

May 13, 2004

TransMID phase III program agreed under SPA

May 13, 2004

SPA for phase III GVAX prostate cancer vaccine trial

May 12, 2004

Novel human anticancer vaccine elicits cellular responses

May 12, 2004

Australian Pentrys phase II trial commences

May 5, 2004

Phase II TroVax trial cleared to commence for metastatic renal cancer

May 3, 2004

Positive data for HuMax-CD4 in phase II CTCL studies

April 30, 2004

Esteve takes marketing rights to Wilex's Rencarex in Southern Europe

April 30, 2004

Phase III results of R-1549 in ovarian cancer disappoint

April 28, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...